Advertisement

Welcome to the new AJNR, Updated Hall of Fame, and more. Read the full announcements.

AJNR is seeking candidates for the position of Associate Section Editor, AJNR Case Collection. Read the full announcement.

 

Research ArticleBRAIN

Whole-Brain Atrophy in Multiple Sclerosis Measured by Automated versus Semiautomated MR Imaging Segmentation

Jitendra Sharma, Michael P. Sanfilipo, Ralph H. B. Benedict, Bianca Weinstock-Guttman, Frederick E. Munschauer and Rohit Bakshi
American Journal of Neuroradiology June 2004, 25 (6) 985-996;

References

  1. ↵
    Zivadinov R, Bakshi R. Role of MRI in multiple sclerosis. II. Brain and spinal cord atrophy. Front Biosci 2004;9:647–664
    PubMedWeb of Science
  2. ↵
    Zivadinov R, Bakshi R. Role of MRI in multiple sclerosis. I. inflammation and lesions. Front Biosci 2004;9:665–683
    PubMedWeb of Science
  3. ↵
    Bakshi R, Miletich RS, Kinkel PR, et al. High-resolution fluorodeoxyglucose positron emission tomography shows both global and regional cerebral hypometabolism in multiple sclerosis. J Neuroimaging 1998;8:228–234
    CrossRefPubMedWeb of Science
  4. ↵
    Cifelli A, Arridge M, Jezzard P, et al. Thalamic neurodegeneration in multiple sclerosis. Ann Neurol 2002;52:650–653
    CrossRefPubMedWeb of Science
  5. ↵
    Bakshi R, Dmochowski J, Shaikh ZA, Jacobs L. Gray matter T2 hypointensity is related to plaques and atrophy in brains of multiple sclerosis patients. J Neurol Sci 2001;185:19–26
    CrossRefPubMedWeb of Science
  6. ↵
    Trapp BD, Peterson J, Ransohoff R, et al. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998;338:278–285
    CrossRefPubMedWeb of Science
  7. ↵
    Simon JH, Kinkel RP, Jacobs L, et al. A Wallerian degeneration pattern in patients at risk for MS. Neurology 2000;5:1155–1160
  8. ↵
    Chard D, Griffin CM, Parker GJ, et al. Brain atrophy in clinically early relapsing-remitting multiple sclerosis. Brain 2002;125:327–337
    Abstract/FREE Full Text
  9. ↵
    Brex PA, Jenkins R, Fox NC, et al. Detection of ventricular enlargement in patients at the earliest clinical stage of MS. Neurology 2000;54:1689–1691
    Abstract/FREE Full Text
  10. Brex PA, Leary SM, O’Riordan JI, et al. Measurement of spinal cord area in clinically isolated syndromes suggestive of multiple sclerosis. J Neurol Neurosurg Psychiatry 2001;70:544–547
    Abstract/FREE Full Text
  11. ↵
    Losseff NA, Wang L, Lai HM, et al. Progressive cerebral atrophy in multiple sclerosis: a serial MRI study. Brain 1996;119:2009–2019
    Abstract/FREE Full Text
  12. ↵
    Rudick RA, Fisher E, Lee JC, et al. Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Neurology 1999;53:1698–704
    Abstract/FREE Full Text
  13. ↵
    Ge Y, Grossman RI, Udupa JK, et al. Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: longitudinal quantitative analysis. Radiology 2000;214:665–70
    PubMedWeb of Science
  14. ↵
    Simon JH, Jacobs LD, Campion MK, et al. A longitudinal study of brain atrophy in relapsing multiple sclerosis. Neurology 1999;53:139–148
    Abstract/FREE Full Text
  15. ↵
    Rovaris M, Comi G, Rocca MA, et al. Short-term brain volume change in relapsing-remitting multiple sclerosis: effect of glatiramer acetate and implications. Brain 2001;124:1803–1812
    Abstract/FREE Full Text
  16. Filippi M, Rovaris M, Iannucci G, et al. Whole brain volume changes in patients with progressive MS treated with cladribine. Neurology 2000;55:1714–1717
    Abstract/FREE Full Text
  17. ↵
    Zivadinov R, Rudick RA, De Masi R, et al. Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS. Neurology 2001;57:1239–1247
    Abstract/FREE Full Text
  18. ↵
    Zivadinov R, Sepcic J, Nasuelli D, et al. A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 2001;70:773–780
    Abstract/FREE Full Text
  19. ↵
    Fisher E, Rudick RA, Simon JH, et al. Eight-year follow-up study of brain atrophy in patients with MS. Neurology 2002;59:1412–1420
    Abstract/FREE Full Text
  20. ↵
    Bakshi R, Benedict RH, Bermel RA, Jacobs L. Regional brain atrophy is associated with physical disability in multiple sclerosis: semiquantitative magnetic resonance imaging and clinical findings. J Neuroimaging 2001;11:129–136
    CrossRefPubMedWeb of Science
  21. ↵
    Benedict RHB, Weinstock-Guttman B, Fishman I, et al. Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden. Arch Neurol 2004;61:226–230
    CrossRefPubMedWeb of Science
  22. ↵
    Bermel R, Bakshi R, Tjoa C, et al. Bicaudate ratio as an MRI marker of brain atrophy in multiple sclerosis. Arch Neurol 2002;59:275–280
    CrossRefPubMedWeb of Science
  23. Janardhan V, Bakshi R. Quality of life and its relationship to brain lesions and atrophy on magnetic resonance images in 60 patients with multiple sclerosis. Arch Neurol 2000;57:1485–1491
    CrossRefPubMedWeb of Science
  24. Bakshi R, Czarnecki D, Shaikh ZA, et al. Brain MRI lesions and atrophy are related to depression in multiple sclerosis. Neuroreport 2000;11:1153–1158
    CrossRefPubMedWeb of Science
  25. ↵
    Bermel RA, Sharma J, Tjoa CW, et al. A semiautomated measure of whole-brain atrophy in multiple sclerosis. J Neurol Sci 2003;208:57–65
    CrossRefPubMedWeb of Science
  26. ↵
    Leigh R, Ostuni J, Pham D, et al. Estimating cerebral atrophy in multiple sclerosis patients from various MR pulse sequences. Mult Scler 2002;8:420–429
    Abstract/FREE Full Text
  27. Zorzon M, de Masi R, Nasuelli D, et al. Depression and anxiety in multiple sclerosis: a clinical and MRI study in 95 subjects. J Neurol 2001;248:416–421
    CrossRefPubMedWeb of Science
  28. ↵
    Miller DH, Barkhof F, Frank JA, et al. Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. Brain 2002;125:1676–1695
    Abstract/FREE Full Text
  29. ↵
    Kalkers NF, Vrenken H, Uitdehaag BMJ, et al. Brain atrophy in multiple sclerosis: impact of lesions and damage of whole brain tissue. Mult Scler 2002;8:410–414
    Abstract/FREE Full Text
  30. ↵
    Chard DT, Parker GJ, Griffin CM, et al. The reproducibility and sensitivity of brain tissue volume measurements derived from an SPM-based segmentation methodology. J Magn Reson Imaging 2002;15:259–267
    CrossRefPubMedWeb of Science
  31. ↵
    Zivadinov R, Bakshi R, Grop A, et al. A comparison of different quantitative MRI techniques to measure whole brain atrophy in relapsing-remitting multiple sclerosis. Mult Scler 2002;8:s99
  32. ↵
    Horsfield MA, Rovaris M, Rocca MA, et al. Whole brain atrophy in multiple sclerosis measured by two segmentation processes from various MRI sequences. J Neurol Sci 2003;216:169–177
    CrossRefPubMedWeb of Science
  33. ↵
    Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444–1452
    Abstract/FREE Full Text
  34. ↵
    Bakshi R, Caruthers SD, Janardhan V, Wasay M. Intraventricular CSF pulsation artifact on fast fluid-attenuated inversion-recovery MR images: analysis of 100 consecutive normal studies. AJNR Am J Neuroradiol 2000;21:503–508
    Abstract/FREE Full Text
  35. ↵
    Bakshi R, Ariyaratana S, Benedict RHB, Jacobs L. Fluid-attenuated inversion recovery magnetic resonance imaging detects cortical and juxtacortical multiple sclerosis lesions. Arch Neurol 2001;58:742–748
    CrossRefPubMedWeb of Science
  36. ↵
    Bastianello S, Bozzao A, Paolillo A, et al. Fast spin-echo and fast fluid-attenuated inversion-recovery versus conventional spin-echo sequences for MR quantification of multiple sclerosis lesions. AJNR Am J Neuroradiol 1997;18:699–704
    Abstract/FREE Full Text
  37. ↵
    Bakshi R, Benedict RHB, Bermel RA, et al. T2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study. Arch Neurol 2002;59:62–68
    CrossRefPubMedWeb of Science
  38. ↵
    Sanfilipo MP, Benedict RHB, Zivadinov R, Bakshi R. Correction for intracranial volume in analysis of whole brain volume in multiple sclerosis: the proportion vs. residual method. Neuroimage (in press)
  39. ↵
    Ashburner J, Friston K. Voxel-based morphometry: the methods. Neuroimage 2000;11:805–821
    CrossRefPubMedWeb of Science
  40. ↵
    Hoogervorst EL, Polman CH, Barkhof F. Cerebral volume changes in multiple sclerosis patients treated with high-dose intravenous methylprednisolone. Mult Scler 2002;8:415–419
    Abstract/FREE Full Text
  41. Hohol MJ, Guttmann CR, Orav J, et al. Serial neuropsychological assessment and magnetic resonance imaging analysis in multiple sclerosis. Arch Neurol 1997;54:1018–1025
    CrossRefPubMedWeb of Science
  42. Pelletier D, Nelson SJ, Oh J, et al. MRI lesion volume heterogeneity in primary progressive MS in relation with axonal damage and brain atrophy. J Neurol Neurosurg Psychiatry 2003;74:950–952
    Abstract/FREE Full Text
  43. ↵
    Gasperini C, Rovaris M, Sormani MP, et al. Intra-observer, inter-observer and inter-scanner variations in brain MRI volume measurements in multiple sclerosis. Mult Scler 2001;7:27–31
    Abstract/FREE Full Text
  44. ↵
    Bakshi R, Puli SR. Tjoa CW, et al. Gray matter T2 hypointensity in multiple sclerosis: a 2-year longitudinal clinical–MRI study of 79 patients. Neurology 2002;58:A154
  45. ↵
    Simon JH. Contrast-enhanced MR imaging in the evaluation of treatment response and prediction of outcome in multiple sclerosis. J Magn Reson Imaging 1997;7:29–37
    PubMedWeb of Science
  46. Katz D. Taubenberger JK, Cannella B, et al. Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis. Ann Neurol 1993;34:661–669
    CrossRefPubMedWeb of Science
  47. Barnes D, Munro PM, Youl BD, et al. The longstanding MS lesion: a quantitative MRI and electron microscopic study. Brain 1991;114:1271–1280
    Abstract/FREE Full Text
  48. Barkhof F. MRI in multiple sclerosis: correlation with expanded disability status scale (EDSS). Mult Scler 1999;5:283–286
    Abstract/FREE Full Text
  49. ↵
    Bakshi R, Miletich RS, Henschel K, et al. Fatigue in multiple sclerosis: cross sectional correlation with brain MRI findings in 71 patients. Neurology 1999;53:1151–1153
    Abstract/FREE Full Text
Back to top

In this issue

Advertisement
Print
Download PDF
Email Article
Cite this article
0 Responses
Respond to this article
Bookmark this article
Whole-Brain Atrophy in Multiple Sclerosis Measured by Automated versus Semiautomated MR Imaging Segmentation
Jitendra Sharma, Michael P. Sanfilipo, Ralph H. B. Benedict, Bianca Weinstock-Guttman, Frederick E. Munschauer, Rohit Bakshi
American Journal of Neuroradiology Jun 2004, 25 (6) 985-996;
del.icio.us logo Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement